Division of Urology becomes 27th School of Medicine department
Christopher Amling, MD, becomes chair
July 10, 2012
The Division of Urology within the Department of Surgery has become a new department in the OHSU School of Medicine, effective July 1, 2012. Christopher Amling, MD, FACS, Professor and Division Chief, is Chair of the Department of Urology.
Since Dr. Amling's arrival at OHSU in 2009, the Division of Urology has grown substantially, with eight new faculty members, steadily increasing patient volume with a diverse portfolio of clinical services, along with significant engagement in the research and education missions. This strategic growth of the Division of Urology mirrors national trends related to this specialty, as many medical schools are increasingly organized with urology as a stand-alone department.
"I am pleased to appoint Chris Amling as our first chair of the Department of Urology," said Dean Mark Richardson. "It is in part due to his skill and demonstrated leadership that the division is positioned to take this step. Please join me in congratulating Chris on his new role."
Faculty formerly in the Division of Urology are primary faculty within the Department of Urology, and Megan Jensen, MBA, is department administrator.
"Our history within the Department of Surgery has been a rich relationship and we appreciate the long-standing partnership which has facilitated our move to a free-standing department," said Dr. Amling. "The department designation offers many advantages for Urology and the institution as a whole, including the increased ability to recruit and retain faculty, which will help establish OHSU as a program of excellence across the nation."
"The Department of Surgery is fully supportive of this change," said John Hunter, MD, Mackenzie Professor and Chair, Department of Surgery. "I have enjoyed working with Chris since his arrival at OHSU to help realize our shared vision of Urology as a free-standing department within the School of Medicine."
Dr. Amling is eager to continue the growth and quality of research, clinical services and training opportunities in the new Department of Urology. As Chair, he will recruit a new faculty member to lead a dedicated urology basic science laboratory – the first of its kind at OHSU. Dr. Amling will also continue his position as Director of the Robotic Surgery Program at OHSU, and aims to establish OHSU as a national leader in minimally invasive robotic surgery. These aspects of the Department of Urology – along with the recent expansion of the ACGME-accredited Urology residency program – will enhance OHSU's already competitive Graduate Medical Education program.
Dr. Amling received his MD degree from the OHSU School of Medicine in 1985. His residency training took place at Duke University Medical Center, and his fellowship in urologic oncology at Mayo Clinic. He served for 20 years in the U.S. Navy rising to the rank of Captain, part of this time serving as a Naval Flight Surgeon with the U.S. Marine Corps. Before joining OHSU, Dr. Amling held academic and leadership positions at the Uniformed Services University of the Health Sciences in Bethesda, Md., the Naval Medical Center in San Diego and the University of Alabama at Birmingham.
Upon his retirement from the U.S. Navy in 2005, Dr. Amling received the Meritorious Service Medal from the Naval Medical Center for contributions as a clinician, researcher, mentor and teacher in the Department of Urology. In 2009, he was the recipient of the prestigious Gold Cystoscope Award awarded annually to an early career urologist deemed to have made significant contributions to the specialty. He is an active member of multiple professional organizations, including the Residency Review Committee for Urology and the Society of University Urologists, serving as president of this organization in 2008-2009. He was recently selected for active membership in the American Surgical Association and the American Association of Genitourinary Surgeons. Dr. Amling is widely published, and will continue his scholarly interests in the treatment of cancers of the urinary and reproductive system, and the utilization of minimally invasive techniques for treating these cancers, including robotic surgery for prostate, bladder and kidney cancer.
Pictured: Dr. Amling